Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
References Chang CH, Tsai WC, Lin MS, et al
compounded only NAD+ Infusion (IV) Not FDA-approved
Its broad interaction across regulatory pathways is one reason BPC-157 remains one of the most frequently cited peptides in experimental models
Research Background & Mechanistic Focus Current research use centers on coordinated cytoskeletal, cellular-migration, and structural-response signaling models, comparative presentation or formulation behavior where applicable, and controlled experimental models designed to evaluate compound-specific signaling activity within non-clinical laboratory systems
The MOQ is 500L
Both target multiple metabolic pathways simultaneously
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
